Rocket Pharmaceuticals, Inc. (RCKT)
2.34
+0.10
(+4.46%)
USD |
NASDAQ |
Oct 20, 16:00
2.38
+0.04
(+1.71%)
After-Hours: 20:00
Rocket Pharmaceuticals Gross Profit (TTM) : -9.706M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.706M |
| March 31, 2026 | -10.14M |
| December 31, 2025 | -10.98M |
| September 30, 2025 | -11.13M |
| June 30, 2025 | -10.28M |
| March 31, 2025 | -10.08M |
| December 31, 2024 | -9.343M |
| September 30, 2024 | -9.348M |
| June 30, 2024 | -8.72M |
| March 31, 2024 | -8.103M |
| December 31, 2023 | -7.522M |
| September 30, 2023 | -6.934M |
| June 30, 2023 | -6.808M |
| March 31, 2023 | -6.652M |
| December 31, 2022 | -6.281M |
| September 30, 2022 | -7.688M |
| June 30, 2022 | -6.853M |
| March 31, 2022 | -5.987M |
| December 31, 2021 | -5.359M |
| September 30, 2021 | -2.804M |
| June 30, 2021 | -2.304M |
| March 31, 2021 | -1.728M |
| December 31, 2020 | -1.172M |
| September 30, 2020 | -0.643M |
| June 30, 2020 | -0.443M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.421M |
| December 31, 2019 | -0.595M |
| September 30, 2019 | -0.591M |
| June 30, 2019 | -0.567M |
| March 31, 2019 | -0.539M |
| December 31, 2018 | -0.33M |
| September 30, 2018 | -0.295M |
| June 30, 2018 | -0.28M |
| March 31, 2018 | -0.259M |
| December 31, 2017 | -0.204M |
| September 30, 2017 | -0.20M |
| June 30, 2017 | -0.178M |
| March 31, 2017 | -0.161M |
| December 31, 2016 | -0.17M |
| September 30, 2016 | -0.15M |
| June 30, 2016 | -0.117M |
| March 31, 2016 | -0.082M |
| December 31, 2015 | -0.045M |
| September 30, 2015 | -0.007M |
| June 30, 2015 | -0.001M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 1.117B |
| Intellia Therapeutics, Inc. | 44.25M |
| Beam Therapeutics, Inc. | 133.79M |
| Arrowhead Pharmaceuticals, Inc. | 643.69M |
| Oncolytics Biotech, Inc. | -0.11M |